Table 1.
Baseline characteristics of 452 CRC patients included in this study.
| Variables | Count | Percentage (%) |
|---|---|---|
| Age (Mean ± SD) | 67.26 ± 13.02 | |
| Follow-up (y) | 2.05 ± 1.98 | |
| Status | ||
| Alive | 88 | 19.47 |
| Dead | 364 | 80.53 |
| Gender | ||
| Male | 238 | 52.65 |
| Female | 214 | 47.34 |
| AJCC-T | ||
| T1 | 10 | 2.21 |
| T2 | 77 | 17.04 |
| T3 | 308 | 68.14 |
| T4 | 56 | 12.39 |
| Tis | 1 | 0.22 |
| AJCC-N | ||
| N0 | 269 | 59.51 |
| N1 | 103 | 22.79 |
| N2 | 80 | 17.70 |
| AJCC-M | ||
| M0 | 334 | 73.89 |
| M1 | 62 | 13.72 |
| MX | 49 | 10.84 |
| Unknow | 7 | 1.55 |
| Pathological stage | ||
| I | 76 | 16.81 |
| II | 178 | 39.38 |
| III | 125 | 27.65 |
| IV | 62 | 13.72 |
| Unknow | 11 | 2.43 |
| Grade | ||
| G1 | – | – |
| G2 | – | – |
| G3 | – | – |
| G4 | – | – |
| Unknow | 452 | 100.00 |
AJCC, American Joint Committee on Cancer.